日期: 2025-08-15
代码: 2591.HK
事件: 股东增减持（股东增减持）
中金资本运营于2025-08-15增持235.3万股，最新持股数目235.3万股，最新持股比例6.44% @#$ CICC Biomedical Fund L.P. holds 6.44% of domestic shares in 2591.HK. Its three LPs—Qingdao Xi'an Huirong Qide, Qingdao Huirong Qide, and Qizhi Huirong (Xiamen)—contributed 6.59%, 7.7%, and 25.55% respectively. All share the same GP, Henan Zhongjin Huirong Private Equity Fund Management Co., Ltd. , which collectively controls 39.84% of the fund through these LP interests.  CICC Capital Management Co., Ltd. is the GP of CICC Biomedical Fund L.P.